Aethlon Medical, Inc. [AEMD] says it will submit a contract response to a recent Broad Agency Announcement for the development and evaluation of category A, B and C bio-terror threats. "Based on pre-clinical data and human treatment experience, I believe our Hemopurifier is the most advanced broad spectrum treatment for viral pathogens identified as bio-terror threats," says James Joyce, chairman and CEO of Aethlon. Under the BAA issued by the National Institute of Allergy and Infectious Diseases and the Biomedical…
Recommended
Trending
Congress Updates
Budd And Shaheen Bill Would Authorize 329 F-15EX Fighters
Two members of the Senate Armed Services Committee (SASC), Sen. Ted Budd (R-N.C.) and Sen. Jeanne Shaheen (D-N.H.), have introduced the Airpower Acceleration Act, which would authorize multi-year procurements of […]
HASC’s Wittman Sees ‘Challenging’ Push For $350B In Reconciliation Funds, Wants Sustained Defense Increase
NATIONAL HARBOR, Md.– Congress’ work to pass $350 billion in reconciliation funds to support the Trump administration’s push for a $1.5 trillion fiscal year 2027 defense topline is “going to […]
Army Secretary Says “We Need To Over-Invest in FLRAA To Get It Online As Quickly As Possible”
Rep. Ken Calvert (R-Calif.), chairman of the House Appropriations Committee’s defense panel (HAC-D), said on Thursday that the Army’s budget plan beginning in fiscal 2027 has more than $2 billion […]
Pentagon Fiscal 2027 Budget To Address Cannibalization Of Parts For F-35, Legislator Says
The Pentagon’s upcoming fiscal 2027 budget request will help reduce the cannibalization of parts for the F-35 fighter by Lockheed Martin [LMT], the chairman of the House Armed Services Committee’s […]
Job Feed
-
Transformational Lead
Data Loss Prevention & Identity Defense - Bank of America - Denver, CO -
Privileged Access Management (PAM) Sr. Analyst
Bank of America - Boston, MA -
Head of Identity and Access Management
Caterpillar Inc - East Peoria, IL -
Manager Cybersecurity
Caterpillar Inc - Tucson, AZ